DocMorris AG (DOCMZ.XC)
- Previous close
8.52 - Open
9.11 - Bid 9.95 x --
- Ask 10.04 x --
- Day's range
9.11 - 10.00 - 52-week range
3.96 - 10.00 - Volume
111,120 - Avg. Volume
18,119 - Market cap (intra-day)
484.728M - Beta (5Y monthly) 1.86
- PE ratio (TTM)
-- - EPS (TTM)
-4.58 - Earnings date --
- Forward dividend & yield --
- Ex-dividend date --
- 1y target est
--
DocMorris AG operates as an online pharmacy, telemedicine, and healthcare company in Switzerland and internationally. The company offers prescription and over-the-counter medicines, and consumer health products, as well as beauty and personal care products, nutritional supplements, painkillers, and first aid products. The company also provides professional health care services to doctors, pharmacies, insurers, and health institutions. It sells its products to online mail-order pharmacies, and private individuals under the DocMorris, PromoFarma by DocMorris, and TeleClinic brands. The company was formerly known as Zur Rose Group AG and changed its name to DocMorris AG in May 2023. DocMorris AG was founded in 1993 and is headquartered in Frauenfeld, Switzerland.
corporate.docmorris.com/en1,097
Full-time employees
31 December
Fiscal year ends
Healthcare
Sector
Pharmaceutical Retailers
Industry
Recent news
View more
Performance overview
Trailing total returns as of 13/07/2026, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .
YTD return
1-year return
3-year return
5-year return
Earnings trends
View moreStatistics
View moreValuation measures
Market cap
420.32M
Enterprise value
500.59M
Trailing P/E
--
Forward P/E
--
PEG ratio (5-yr expected)
--
Price/sales (ttm)
0.39
Price/book (mrq)
0.87
Enterprise value/revenue
0.47
Enterprise value/EBITDA
--
Financial highlights
Profitability and income statement
Profit margin
-11.95%
Return on assets (ttm)
-7.67%
Return on equity (ttm)
-35.88%
Revenue (ttm)
1.12B
Net income avi to common (ttm)
-134.4M
Diluted EPS (ttm)
-4.58
Balance sheet and cash flow
Total cash (mrq)
159.48M
Total debt/equity (mrq)
70.56%
Levered free cash flow (ttm)
-73.36M
Compare
Select to analyse similar companies using key performance metrics; select up to four stocks.